AM, S., M, G., A, P., & AJ, G. (2023). Lack of Access to Rifaximin Upon Hospital Discharge Is Frequent and Results in Increased Hospitalizations for Hepatic Encephalopathy. The Annals of pharmacotherapy, 57(2), 133. https://doi.org/10.1177/10600280221100537
Chicago Style (17th ed.) CitationAM, Stoll, Guido M, Pence A, and Gentene AJ. "Lack of Access to Rifaximin Upon Hospital Discharge Is Frequent and Results in Increased Hospitalizations for Hepatic Encephalopathy." The Annals of Pharmacotherapy 57, no. 2 (2023): 133. https://doi.org/10.1177/10600280221100537.
MLA (9th ed.) CitationAM, Stoll, et al. "Lack of Access to Rifaximin Upon Hospital Discharge Is Frequent and Results in Increased Hospitalizations for Hepatic Encephalopathy." The Annals of Pharmacotherapy, vol. 57, no. 2, 2023, p. 133, https://doi.org/10.1177/10600280221100537.